Demographic Data |
Relation to Proband |
proband |
Age at Sampling |
6 YR |
Sex |
Male |
Age of Onset(If not a control) |
2 YR |
Age at Diagnosis(If not a control) |
6 YR |
Hispanic or Latino/Not Hispanic or Latino |
Not Hispanic/Latino |
Racial Category |
White |
Country |
CANADA |
|
Data Elements |
Clinical Element Type: General NIGMS Catalog Remarks |
(Baseline) |
Mutation Information |
Gene, variant, consequence, and exon number: |
SPAST, C.1413+1G>A, EXON 11 |
Zygosity: |
Heterozygous |
Age of Symptom Onset and Age at Diagnosis |
Age of Symptom Onset: |
2 YEARS |
Age at Diagnosis: |
6 YEARS |
In Utero History Information |
|
|
Birth History Information |
|
|
Dysmorphic Features |
|
|
Neurological Symptoms |
|
|
Optical and Audiological Symptoms |
|
|
Musculoskeletal Symptoms |
|
|
Additional Information: |
STIFF LEG MUSCLES |
Developmental Milestones |
|
|
Gastrointestinal Symptoms |
|
|
Genitourinary Symptoms |
|
|
Respiratory and Cardiovascular Symptoms |
|
|
Cognitive and Behavioral Symptoms |
|
|
Additional Information |
Uncategorized Symptoms: |
INTOEING (TOES POINT IN) |
Testing Performed |
Treatments and Assistive Devices |
|
Physical therapy
|
Additional Testing: |
MASSAGE THERAPY |
Medications |
Family History |
Remarks |
See "Phenotypic Data" Tab. Heterozygous for the pathogenic variant. c.1413+1G>A, in the SPAST gene. The variant affects the canonical +1 splice site of exon 11 and is likely to affect splicing. Unaffected mother is GM29368 (fibro) |